Put company on watchlist
Epigenomics AG
ISIN: DE000A37FT41
WKN: A37FT4
About
Company Snapshot
New: Activate notification
Be informed about new publications
New: AI Factsheet

Coming soon: Summary of the company message by AI/p>

Epigenomics AG · ISIN: DE000A37FT41 · Newswire (Company)
Country: Deutschland · Primary market: Germany · EQS NID: 1827313
31 January 2024 15:30PM

Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board


EQS-News: Epigenomics AG / Key word(s): Personnel
Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board

31.01.2024 / 15:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board

Berlin, January 31, 2024 - Epigenomics AG (Frankfurt General Standard: ECX; the "Company"), a holding company focusing on investments in the field of minimally invasive blood tests for cancer detection, announces that the Supervisory Board has appointed Mr. Hansjörg Plaggemars to the Executive Board effective February 1, 2024.

Hansjörg Plaggemars (53) has more than 20 years of management experience in finance in various European companies.

He started his career at KPMG Corporate Finance and has worked as a CFO for over 14 years in various industries, including software, retail, prefabricated housing and e-commerce. In 2014, Mr. Plaggemars joined Deutsche Balaton AG and founded his own consulting firm, Value Consult, in 2017. In this role, he supports various projects, mainly with a capital market orientation, in different functions and industries.

Hansjörg Plaggemars holds a degree in business administration from the University of Bamberg.

Dr. Helge Lubenow, Chairwoman of the Supervisory Board: „We are very pleased that Mr. Plaggemars with his extensive management experience and expertise in finance is joining Epigenomics AG.“

„I am looking forward to becoming part of the Epigenomics team,“ said Hansjörg Plaggemars.

 

Contact:
Company
Epigenomics AG, Bertha-Benz-Strasse 5, 10557 Berlin
Tel +49 (0) 30 24345 0, Fax +49 (0) 30 24345 555, Email: contact@epigenomics.com

Investor Relations
IR.on AG, Frederic Hilke, Tel +49 221 9140 970, Email: ir@epigenomics.com


Note on forward-looking statements

This publication expressly or implicitly contains forward-looking statements concerning Epigenomics AG and its business. These statements involve certain known and unknown risks, uncertainties and other factors that may cause Epigenomics AG's actual results, financial condition and performance to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Epigenomics makes this announcement as of the date of this release and does not intend to update any forward-looking statements contained herein as a result of new information or future events or otherwise.

 



31.01.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Epigenomics AG
Bertha-Benz-Straße 5
10557 Berlin
Germany
Phone: +49 30 24345-0
Fax: +49 30 24345-555
E-mail: ir@epigenomics.com
Internet: www.epigenomics.com
ISIN: DE000A37FT41
WKN: A37FT4
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1827313

 
End of News EQS News Service

1827313  31.01.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1827313&application_name=news&site_id=boersengefluester_html
smart.AD

Trading Solutions for Professionals

  • 25 kinds of clusters
  • 26 world exchanges
  • 14 different charts
  • 58 necessary for analysis indicators
  • 50+ customized templates for charts


Get your free Demo today

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 04.11.2024, Calendar Week 45, 309th day of the year, 57 days remaining until EoY.